What is the recommended screening method for Chlamydia and Gonorrhea in sexually active women under 25?

The recommended screening method for Chlamydia and Gonorrhea in sexually active women under 25 is annual urine or swab tests. This approach is endorsed by health organizations such as the Centers for Disease Control and Prevention (CDC) because it effectively identifies asymptomatic infections in this age group, who are at a higher risk for these sexually transmitted infections (STIs).

Annual urine tests are non-invasive and easy for patients to provide, making them a practical choice for routine screening. Swab tests can be conducted during a pelvic exam and are also effective in diagnosing these STIs. Regular screening is crucial since many women may not exhibit symptoms, yet still be at risk for severe complications, including pelvic inflammatory disease (PID) or infertility if left untreated.

Blood tests are not a standard method for screening Chlamydia and Gonorrhea, as these infections are typically detected more accurately through urine or swab tests. While pelvic exams and vaginal cultures may be utilized in diagnosing other conditions or when specific symptoms are present, they are not the primary recommendation for routine screening in asymptomatic sexually active women under 25.